• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

["通过“无痛指数”评估治疗乳腺癌骨转移的有效性"]

[Evaluation of the effectiveness of treating breast cancer metastases to the bones by the "no-pain index"].

作者信息

Denisov L E, Ermolaeva E V, Iarygin L M, Nikiforov A M

出版信息

Vopr Onkol. 1981;27(5):14-7.

PMID:7245666
Abstract

The results of evaluation of treatment of 98 breast cancer patients with bone metastases are presented. Metastases appeared 6 months -- 15 years after treatment; on the average, they appeared 20.2 months after treatment. Patients received complex therapy -- radiation and medication. The results of treatment were assessed on the basis of subjective (abatement or cessation of pain) and objective (bone reparation) criteria. Objective effect was observed in 4%, subjective one -- in 68.3% of cases. Apart from survival time and remission, the results of treatment were evaluated on the basis of the duration of painless period expressed by means of "no-pain index" -- the ratio of the painless period duration to survival time which elapsed since skeletal metastasis detection, multiplied by 100. The study showed that complex therapy has a considerable palliative effect in some cases -- abatement or cessation of pain for over 54--60% of the survival time of patients.

摘要

本文介绍了98例乳腺癌骨转移患者的治疗评估结果。转移发生在治疗后6个月至15年;平均而言,转移出现在治疗后20.2个月。患者接受了综合治疗——放疗和药物治疗。治疗结果根据主观(疼痛减轻或停止)和客观(骨修复)标准进行评估。4%的病例观察到客观效果,68.3%的病例观察到主观效果。除了生存时间和缓解情况外,治疗结果还根据通过“无痛指数”表示的无痛期持续时间进行评估——无痛期持续时间与自骨骼转移检测以来所经历的生存时间之比,再乘以100。研究表明,综合治疗在某些情况下具有相当大的姑息作用——在患者超过54%至60%的生存时间内疼痛减轻或停止。

相似文献

1
[Evaluation of the effectiveness of treating breast cancer metastases to the bones by the "no-pain index"].["通过“无痛指数”评估治疗乳腺癌骨转移的有效性"]
Vopr Onkol. 1981;27(5):14-7.
2
Clinical trials in metastatic breast cancer to bone: past--present--future.转移性乳腺癌骨转移的临床试验:过去——现在——未来
Can J Oncol. 1995 Dec;5 Suppl 1:16-27.
3
[Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].[血清Ca 15-3抗原升高:乳腺癌远处转移的早期指标。733例回顾性分析]
Przegl Lek. 2001;58(6):498-503.
4
[Therapy of bone metastases in breast cancer].[乳腺癌骨转移的治疗]
Zentralbl Chir. 1984;109(7):483-9.
5
[186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.[186铼]羟乙膦酸二钠用于缓解除前列腺癌和乳腺癌以外的其他癌症引起的骨转移疼痛。
Q J Nucl Med Mol Imaging. 2006 Dec;50(4):355-62.
6
Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.一项II期试验,评估二线唑来膦酸对一线双膦酸盐治疗后出现骨相关事件或骨转移进展的乳腺癌患者的姑息治疗效果。
J Clin Oncol. 2006 Oct 20;24(30):4895-900. doi: 10.1200/JCO.2006.05.9212. Epub 2006 Sep 25.
7
[Bone metastasis in breast carcinoma].
Zentralbl Chir. 1997;122(2):97-102.
8
[Radiotherapy of osseous metastases in breast cancer].
Geburtshilfe Frauenheilkd. 1991 Feb;51(2):106-8. doi: 10.1055/s-2007-1023684.
9
Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study.使用磁共振引导聚焦超声手术缓解骨转移患者的疼痛:一项多中心研究。
Ann Surg Oncol. 2009 Jan;16(1):140-6. doi: 10.1245/s10434-008-0011-2. Epub 2008 Nov 11.
10
Surgical treatment of bone metastases in patients with breast cancer.乳腺癌患者骨转移的外科治疗
Clin Orthop Relat Res. 2002 Mar(396):191-6.